Resultados de la búsqueda 1921-1930 of 11147 for praluent side afects

  1. Neurología - Ensayos clínicos - Mayo Clinic

    ... adverse events, perioperative morbidity, and health related quality of life. Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide ...

  2. Epilepsia - Médicos y departamentos - Mayo Clinic

    Epilepsy & Seizures Discussions. earlylonghauler · Any Briviact Side Effects? 19 Replies Sat, Feb 07, 2026.

  3. Epilepsia - Médicos y departamentos - Mayo Clinic

    Epilepsy & Seizures Discussions. earlylonghauler · Any Briviact Side Effects? 19 Replies Sat, Feb 07, 2026.

  4. Epilepsia - Médicos y departamentos - Mayo Clinic

    Epilepsy & Seizures Discussions. earlylonghauler · Any Briviact Side Effects? 19 Replies Sat, Feb 07, 2026.

  5. Opciones de métodos anticonceptivos: aspectos para considerar - Mayo Clinic

    Effectiveness, safety and comparative side effects. In: Contraceptive Technology. 22nd ed. ProQuest Ebook Central. Jones & Barlett Learning; 2025. Accessed ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to understand the effects of physical activity compared with health education on memory, attention, and brain health in women with breast cancer ...

  7. Oncología (médica) - Ensayos clínicos

    This study aims to understand the effects of physical activity compared with health education on memory, attention, and brain health in women with breast cancer ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to understand the effects of physical activity compared with health education on memory, attention, and brain health in women with breast cancer ...

  9. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as ...

  10. Oncología (médica) - Ensayos clínicos

    ... negative Squamous Cell Carcinoma of the Head and Neck (SCCHN) initiated at completion of primary treatment (Arm A) or at the time of recurrence (Arm B) ...